607 Impact of anifrolumab on neuropsychiatric manifestations of depression and suicidality in patients with systemic lupus erythematosus

• ,
• Raj Tummala,
• Susan Manzi,
• Gabriel Abreu,
• Catharina Lindholm,
• Ihor Hupka,
• Manish Shroff,
• Shanti Werther

Affiliations

4Global Patient Safety, BioPharmaceuticals, RandD, AstraZeneca, Gaithersburg, MD, USA

Raj Tummala

BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA

Susan Manzi

Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA

Gabriel Abreu

6AstraZeneca, Gothenburg, Sweden

Catharina Lindholm

2Clinical Development, Late Respiratory and Immunology, BioPharmaceuticals RandD, AstraZeneca, Gothenburg, Sweden

Ihor Hupka

3Clinical Development, Late Respiratory and Immunology, BioPharmaceuticals RandD, AstraZeneca, Warsaw, Poland

Manish Shroff

5Global Patient Safety, Vaccines and Immune Therapy, RandD, AstraZeneca, Boston, MA, USA

Shanti Werther

7Global Patient Safety, Biopharmaceuticals, RandD, AstraZeneca, Gothenburg, Sweden